Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (groß) | News | Bilanz/GuV | Dividende/HV | Zertifikate | Depot |
Times + Sales | Chart-Analyse | Analysen | Schätzungen | Termine | Optionsscheine | Watchlist |
Börsenplätze | Chartvergleich | Kursziele | Vergleich | Profil | Knock-Outs | Kaufen |
Orderbuch | Realtime Stuttgart | Fundamentalanalyse | Insidertrades | Fonds | Senden | |
Historisch | Realtime Push | myNews | Anleihen | im Forum |
Inhaber | in % |
---|---|
Freefloat | 43,77 |
ARCH Venture Partners LLC | 22,93 |
SB Investment Advisers (UK) Ltd. | 17,80 |
SB Investment Advisers (UK) Ltd. | 17,75 |
Capital Research & Management Co. (International Investors) | 8,87 |
Vir Investors LLC | 7,96 |
GlaxoSmithKline Plc | 6,03 |
Vanguard Group, Inc. (Subfiler) | 4,49 |
Temasek Holdings Pte Ltd. | 4,32 |
Temasek Holdings Pte Ltd. (Investment Management) | 4,32 |
2017 | 2018 | 2019 | |
---|---|---|---|
Personal am Ende des Jahres | - | - | 229 |
Umsatz pro Mitarbeiter in Mio. USD | - | - | 0,04 |
2017 | 2018 | 2019 | |
---|---|---|---|
Summe Umlaufvermögen | 192 | 118 | 403 |
Summe Anlagevermögen | 224 | 130 | 425 |
Summe Aktiva | 252 | 192 | 512 |
2017 | 2018 | 2019 | |
---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 0 | 0 | 1 |
Summe Fremdkapital | 28 | 62 | 88 |
Summe Eigenkapital | 224 | 130 | 424 |
Summe Passiva | 252 | 192 | 512 |
499 Illinois Street, 94158 San Francisco | |
Tel: | 1.415.906.4324 |
Fax: | |
Internet | http://www.vir.bio |
Alex L. Bangs Chief Information Officer |
Antonio Lanzavecchia Senior Vice President |
Charles Elliott Sigal Independent Director |
David L. Gollaher Head-Policy & Government Affairs |
Dipchand V. Nishar Independent Director |
Dipchard Nishar Director |
George A. Scangos President, Chief Executive Officer & Director |
Herbert W. Virgin Chief Scientific Officer & Executive VP-Research |
Howard Horn CFO, Secretary & Principal Accounting Officer |
Janet Ann Napolitano Director |
Jay Parrish Chief Business Officer |
Jeffrey S. Hatfield Director |
Lynne Krummen SVP-Regulatory Affairs & Program Leadership |
Michael E. Kamarck Chief Technology Officer |
Neera D. Ravindran Head-Investor Relations & Strategic Communications |
Phil Pang Chief Medical Officer |
Phillip A. Sharp Independent Director |
Robert J. More Independent Director |
Robert J. Perez Independent Director |
Robert Taylor Nelsen Independent Director |
Sona Saira Ramasastry Director |
Steven Rice Chief Human Resources Officer |
Vicki L. Sato Non-Executive Chairman |
Online Brokerage über finanzen.net
ETF-Sparplan